Navigation Links
Robbins & Myers Announces Regular Quarterly Cash Dividend
Date:10/4/2007

DAYTON, Ohio, Oct. 4 /PRNewswire-FirstCall/ -- Robbins & Myers, Inc. (NYSE: RBN) announced today that its Board of Directors approved a regular quarterly cash dividend payment of $0.065 per share. The dividend is payable on November 9, 2007 to shareholders of record as of October 16, 2007.

Robbins & Myers, Inc. is a leading global supplier of highly engineered, application-critical equipment and systems to the energy, chemical, pharmaceutical and industrial markets.


'/>"/>
SOURCE Robbins & Myers, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...d to academic achievement, study finds , ...diovascular system in young adulthood may boost br... overall success later in life, new research sugge...ow (or should know) the benefits of exercise and i...study, appearing in this week,s online issue of th...
(Date:12/1/2009)... For many employers, the issue of ... just an employee benefit, it,s providing for the ...ores, Inc. is leading this effort, with the help o...ness center at its corporate offices, bringing qua...to employees and their dependents. ,, Beginn...
(Date:12/1/2009)... US Farms, Inc., (OTC: US... Wellness products is pleased to announce it has s...ia Micro-Lending Institution: Angels In Action ( w...rms, Inc. stated, "We are pleased to announce this...tilizing our Aloe365.com product line. We are dedi...
(Date:12/1/2009)... Gooooooaaaaaal! Cuties® C...2009/2010 growing season with a fresh starting lin...s, soccer. Joy Fawcett - an award-winning soccer ...fforts to celebrate and mentor moms on the sidelin...pansion into Texas and a community-based Web site ...
(Date:12/1/2009)...en may up chances of disease, study finds , ...ms may actually boost the risk of breast cancer in...Dutch researchers analyzed six previously publishe...adiation exposure from mammography among women wit... and two looking at the effect of radiation from s...
Breaking Medicine News(10 mins):Health News:Exercise May Lead to a Smarter, More Successful You 2Health News:Exercise May Lead to a Smarter, More Successful You 3Health News:Hobby Lobby Selects Concentra to Open Health Center 2Health News:Hobby Lobby Selects Concentra to Open Health Center 3Health News:US Farms, Inc. Announces Marketing Agreement With Micro Lending Institution Angels In Action 2Health News:US Farms, Inc. Announces Marketing Agreement With Micro Lending Institution Angels In Action 3Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 2Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 3Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 4Health News:Mammograms May Boost Cancer Risk in High-Risk Women 2
...tion Extends Pace,s Laboratory Network to the West...vices, Inc.,(Pace Analytical) is pleased to announ...al Services, Inc., has purchased the assets of Lau...RCRA and CWA programs. For more than 100 years, La...
... women in Iowa are much more likely to suffer from...rparts, a new University of Iowa study shows. , I...unties, UI psychologist Lisa Segre found that 40 p...ent of new mothers with a household income of $80,...
...go hospital one of 5 percent in the nation to rece... American Nurses,Credentialing Center (ANCC) has a...designation for its excellence in nursing practice... standard,in nursing excellence., (Photo: http:/...
...s show patients live average of 4 years longer tha...ESDAY, Feb. 19 (HealthDay News) -- The lack of a c...ssive brain tumor respond better to a new treatmen.... A study of 25 people with the condition showed t...
...HILL, N.C., Feb. 19 With sales forces shrinking,a...ooling to the constant,demand for rep time, winnin...ore challenging. In response, leading pharma compa... to recent,research from pharmaceutical benchmarki...
...HERSBURG, MD February 19, 2008 A recent survey o...ined current attitudes and practices when caring f..., revealed that most respondents (70 percent) feel...was sponsored by MedImmune, Inc. , The incidence ...
Other Medicine News:Health News:Pace Analytical Services, Inc., Purchases Laucks Testing Laboratory, Inc. 2Health News:Study: low-income women more likely to suffer from postpartum depression 2Health News:Study: low-income women more likely to suffer from postpartum depression 3Health News:Sharp Memorial Hospital Achieves Highest Honor for Nursing Excellence 2Health News:Missing Chromosome Improves Response to Brain Tumor Treatment 2Health News:Building an Effective Sales Force to Serve the U.S. Hospital Market 2Health News:Neonatologists and pediatricians highlight progress and barriers to preemie care 2Health News:Neonatologists and pediatricians highlight progress and barriers to preemie care 3
(Date:12/1/2009)...WATER, Fla., Dec. 1 CCS Medical, I...al supplies, today announced that it has received ...or District of Delaware (the "Court") for its bidd...d proposed sale of substantially all of its assets...09, the Court approved bidding procedures for the ...
(Date:12/1/2009)...A, Va., Dec. 1 CEL-SCI C...gy company and a developer of vaccines and therape...us diseases, announced today that it has retained ... Organization (CRO) to run CEL-SCI,s upcoming Phas...neck cancer with the Company,s lead product candid...
(Date:12/1/2009)...AUREL, N.J., Dec. 1 Me...f technology-enabled clinical documentation servic... from Primordial Design, Inc. has been integrated ...me speech recognition system. The solution is bein...h America (RSNA) convention November 29 through De...
Breaking Medicine Technology:CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 3MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology 2Drinking Your Way to Health 3F Perhaps Not 59700 1Drinking Your Way to Health 3F Perhaps Not 59700 2Drinking Your Way to Health 3F Perhaps Not 59700 3UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 1UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 2UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 3UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 4UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 5UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 6UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 7UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 8UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 9UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 10UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 11UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 12Video Games Can Play Havoc With Kids Joints 59696 1Video Games Can Play Havoc With Kids Joints 59696 2Video Games Can Play Havoc With Kids Joints 59696 3
...NGTON, May 28 Robert Brackett, chief,science offi...), today,released the following statement in respo...rates reported in the latest issue of the Journal ...welcome the findings reported in today,s issue of ...AMA) indicating that the rise in,childhood and tee...
... SAN FRANCISCO, Calif., May 28 Sunesis,Pharmaceut...m ongoing,clinical trials of voreloxin (formerly S...., Updated interim data from Sunesis, ongoing Pha...tant ovarian cancer patients will be presented,dur... (ASCO) Annual Meeting,being held May 30 - June 3,...
Other Medicine Technology:Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress 2Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress 3
Carpentier-Edwards PERIMOUNT Magna Aortic Heart Valve
Dimension Vista System
...background in high performance ultrasound design p...iography. Echocardiography imaging requires superi...tive Doppler performance. The Terason Echo Ultraso...ech Architecture, delivers a compact imaging platf...
...background in high performance portable ultrasound... echocardiography. Echocardiography (ultrasound) ... frame rates, and sensitive Doppler performance. ...ason's proprietary Teratech Architecture, delivers...
Medicine Products: